Suppr超能文献

与结核分枝杆菌的慢性感染作斗争:细胞介导的清除如何逃避以及击败它们的新策略。

Fighting Persistence: How Chronic Infections with Mycobacterium tuberculosis Evade T Cell-Mediated Clearance and New Strategies To Defeat Them.

机构信息

Michigan State University, East Lansing, Michigan, USA.

Michigan State University, East Lansing, Michigan, USA

出版信息

Infect Immun. 2020 Jun 22;88(7). doi: 10.1128/IAI.00916-19.

Abstract

Chronic bacterial infections are caused by pathogens that persist within their hosts and avoid clearance by the immune system. Treatment and/or detection of such pathogens is difficult, and the resulting pathologies are often deleterious or fatal. There is an urgent need to develop protective vaccines and host-directed therapies that synergize with antibiotics to prevent pathogen persistence and infection-associated pathologies. However, many persistent pathogens, such as , actively target the very host pathways activated by vaccination. These immune evasion tactics blunt the effectiveness of immunization strategies and are impeding progress to control these infections throughout the world. Therefore, it is essential that immune evasion-related pathogen virulence strategies are considered to maximize the effectiveness of potential new treatments. In this review, we focus on how infects antigen-presenting cells and evades effective immune clearance by the adaptive response through (i) manipulating antigen presentation, (ii) repressing T cell-activating costimulatory molecules, and (iii) inducing ligands that drive T cell exhaustion. In this context, we will examine the challenges that bacterial virulence strategies pose to developing new vaccines. We will then discuss new approaches that will help dissect immune evasion mechanisms and devise strategies to bypass them to promote long-term protection and prevent disease progression.

摘要

慢性细菌性感染是由病原体引起的,这些病原体在宿主体内持续存在,并逃避免疫系统的清除。治疗和/或检测这些病原体很困难,由此产生的病变通常是有害的或致命的。迫切需要开发保护性疫苗和宿主定向疗法,与抗生素协同作用,以防止病原体持续存在和感染相关的病变。然而,许多持续性病原体,如 ,积极针对疫苗接种激活的宿主途径。这些免疫逃避策略削弱了免疫接种策略的有效性,并阻碍了在全球范围内控制这些感染的进展。因此,必须考虑与免疫逃避相关的病原体毒力策略,以最大限度地提高潜在新疗法的有效性。在这篇综述中,我们重点关注 如何感染抗原呈递细胞,并通过(i)操纵抗原呈递、(ii)抑制 T 细胞激活共刺激分子和(iii)诱导驱动 T 细胞耗竭的配体,从而逃避适应性反应的有效免疫清除。在这种情况下,我们将研究细菌毒力策略对开发新疫苗带来的挑战。然后,我们将讨论有助于剖析 免疫逃避机制并设计绕过这些机制的策略的新方法,以促进长期保护和防止疾病进展。

相似文献

2
Evasion and subversion of antigen presentation by Mycobacterium tuberculosis.结核分枝杆菌对抗抗原呈递的逃避与颠覆
Tissue Antigens. 2009 Sep;74(3):189-204. doi: 10.1111/j.1399-0039.2009.01301.x. Epub 2009 Jun 25.
7
Mycobacterium tuberculosis: immune evasion, latency and reactivation.结核分枝杆菌:免疫逃避、潜伏和再激活。
Immunobiology. 2012 Mar;217(3):363-74. doi: 10.1016/j.imbio.2011.07.008. Epub 2011 Jul 18.
10
Analyzing the interaction of pathogens with the host immune system.分析病原体与宿主免疫系统的相互作用。
Immunol Lett. 2009 Feb 21;122(2):112-4. doi: 10.1016/j.imlet.2008.11.016. Epub 2009 Jan 7.

引用本文的文献

8
Host-Directed Therapies for Tuberculosis.结核病的宿主导向疗法
Pathogens. 2022 Nov 3;11(11):1291. doi: 10.3390/pathogens11111291.
9
Review of Pediatric Tuberculosis in the Aftermath of COVID-19.新冠疫情后儿童结核病综述
Clin Pract. 2022 Sep 11;12(5):738-754. doi: 10.3390/clinpract12050077.
10
Immune evasion and provocation by Mycobacterium tuberculosis.结核分枝杆菌的免疫逃逸和免疫激发。
Nat Rev Microbiol. 2022 Dec;20(12):750-766. doi: 10.1038/s41579-022-00763-4. Epub 2022 Jul 25.

本文引用的文献

1
Prevention of tuberculosis in macaques after intravenous BCG immunization.静脉内 BCG 免疫后猕猴结核病的预防。
Nature. 2020 Jan;577(7788):95-102. doi: 10.1038/s41586-019-1817-8. Epub 2020 Jan 1.
7
The next generation of CRISPR-Cas technologies and applications.下一代 CRISPR-Cas 技术与应用
Nat Rev Mol Cell Biol. 2019 Aug;20(8):490-507. doi: 10.1038/s41580-019-0131-5.
9
Mycobacterial Evolution Intersects With Host Tolerance.分枝杆菌进化与宿主耐受相交织。
Front Immunol. 2019 Mar 22;10:528. doi: 10.3389/fimmu.2019.00528. eCollection 2019.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验